(Q40575940)

21 September 2017

1 reference

title

Thrombolysis in ischaemic stroke--how far from a clinical breakthrough? (English)

1 reference

21 September 2017

1 reference

Boysen G

1

1 reference

21 September 2017

Overgaard K

series ordinal

2

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

Journal of Internal Medicine

21 September 2017

published in

1 reference

21 September 2017

volume

237

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

95-103

1 reference

Stroke incidence and risk factors for stroke in Copenhagen, Denmark.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Stroke incidence in Copenhagen, 1976-1988

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Cause of cerebral infarction in the carotid territory. Its relation to the size and the location of the infarct and to the underlying vascular lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Thrombolytic therapy in acute ischemic stroke. A Danish pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Thrombolysis with fibrinolysin in cerebral arterial occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Hemorrhagic transformation in cardioembolic cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

Hemorrhagic infarct of the brain without a reopening of the occluded arteries in cardioembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01146.X

10.1111/J.1365-2796.1995.TB01146.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference